SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
Pactiv Evergreen Inc. (PTVE) , forward earnings yield 7.92%.
Criteria proven by this page:
- VALUE (35/100, Fail) — the composite valuation score falls below the 60/100 threshold required to pass.
- Forward P/E 12.6
- Analyst consensus target $18.00 (-0.1% downside) — slight downside risk — the market may be ahead of analyst expectations.
Overall SharesGrow Score: 37/100 with 0/7 criteria passed.
SharesGrow 7-Criteria Score
✗
VALUE
35/100
Price-to-Earnings & upside
Proven by this page
✗
HEALTH
33/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — PTVE
Valuation Multiples
P/E (TTM)0.0
Forward P/E12.6
PEG RatioN/A
Forward PEGN/A
P/B Ratio0.00
P/S Ratio0.67
EV/EBITDA0.0
Per Share Data
EPS (TTM)$-0.74
Forward EPS (Est.)$1.43
Book Value / Share$0.00
Revenue / Share$26.74
FCF / Share$0.00
Yields & Fair Value
Earnings YieldN/A
Forward Earnings Yield7.92%
Dividend Yield0.00%
Analyst Target$18.00 (-0.1%)
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2015 |
$13.19 |
$11.18B |
$2.32B |
20.7% |
| 2016 |
$0.91 |
$10.65B |
$159M |
1.5% |
| 2017 |
$2.49 |
$10.52B |
$437M |
4.2% |
| 2018 |
$-0.04 |
$10.66B |
$-7M |
-0.1% |
| 2019 |
$4.46 |
$9.72B |
$183M |
1.9% |
| 2020 |
$-0.07 |
$4.69B |
$-10M |
-0.2% |
| 2021 |
$0.19 |
$5.44B |
$33M |
0.6% |
| 2022 |
$1.77 |
$6.22B |
$318M |
5.1% |
| 2023 |
$-1.25 |
$5.51B |
$-223M |
-4% |
| 2024 |
$-0.74 |
$4.81B |
$-133M |
-2.8% |
